Discover the complete record of transactions filed by CONWAY ROBERT E, Director. Director active across 3 companies, notably ARCA biopharma, Inc.. Cumulatively, 10 filings have been logged. Total volume traded: €762k. The latest transaction was disclosed on 23 September 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Robert E. Conway is a Director of ARCA biopharma, Inc. and ALPINE IMMUNE SCIENCES, INC. He brings extensive experience in corporate governance and strategic decision-making. His role involves overseeing the company's activities and ensuring that shareholder interests are safeguarded. His contribution is essential in guiding these companies within the biopharmaceutical sector.